Rossari Biotech Limited (ROSSARI) - Total Liabilities

Latest as of September 2025: Rs8.36 Billion INR ≈ $90.46 Million USD

Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) has total liabilities worth Rs8.36 Billion INR (≈ $90.46 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Rossari Biotech Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how Rossari Biotech Limited's total liabilities have evolved over time, based on quarterly financial data. See ROSSARI working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Rossari Biotech Limited Competitors by Total Liabilities

The table below lists competitors of Rossari Biotech Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Ld Intelligent Technology Co Ltd SHE:300883	China	CN¥1.24 Billion
Tus Pharmaceutical Group Co Ltd SHE:000590	China	CN¥333.17 Million
Rotshtein TA:ROTS	Israel	ILA1.57 Billion
Materialise NV NASDAQ:MTLS	USA	$162.93 Million
Shenzhen Ecobeauty Co Ltd SHE:000010	China	CN¥2.31 Billion
Zhejiang Dayang Biotech Group Co SHE:003017	China	CN¥706.73 Million
Alandsbanken Abp A HE:ALBAV	Finland	€4.84 Billion
Formosan Union Chemical Corp TW:1709	Taiwan	NT$3.13 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Rossari Biotech Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Rossari Biotech Limited.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.73	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.67	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rossari Biotech Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rossari Biotech Limited (2017–2025)

The table below shows the annual total liabilities of Rossari Biotech Limited from 2017 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs7.11 Billion ≈ $76.86 Million	+35.53%
2024-03-31	Rs5.24 Billion ≈ $56.71 Million	+15.92%
2023-03-31	Rs4.52 Billion ≈ $48.93 Million	+0.19%
2022-03-31	Rs4.52 Billion ≈ $48.83 Million	+195.96%
2021-03-31	Rs1.53 Billion ≈ $16.50 Million	-17.45%
2020-03-31	Rs1.85 Billion ≈ $19.99 Million	+46.66%
2019-03-31	Rs1.26 Billion ≈ $13.63 Million	+61.85%
2018-03-31	Rs778.70 Million ≈ $8.42 Million	+13.00%
2017-03-31	Rs689.09 Million ≈ $7.45 Million	--

About Rossari Biotech Limited

NSE:ROSSARI India Specialty Chemicals

Market Cap

$319.65 Million

Rs29.56 Billion INR

Market Cap Rank

#14609 Global

#728 in India

Share Price

Rs533.70

Change (1 day)

+4.15%

52-Week Range

Rs378.60 - Rs743.30

All Time High

Rs1568.62